⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACET News
Adicet Bio, Inc. Common Stock
Form 8-K
sec.gov
ACET
OTC Medicines Play Central Role in How Americans Manage Health, New Study Finds
prnewswire.com
ACET
CLAR
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
businesswire.com
ACET
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
businesswire.com
ACET
Adicet Bio Announces Reverse Stock Split
businesswire.com
ACET
Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
businesswire.com
ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
ACET
Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2 nd Annual Healthcare Innovation Conference
businesswire.com
ACET
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
businesswire.com
ACET